The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
To pursue a systematic approach to the discovery of functional connections among diseases, genetic perturbation, and drug action, we have created the first installment of a reference collection of gene-expression profiles from cultured human cells treated with bioactive small molecules, together with pattern-matching software to mine these data. We demonstrate that this “Connectivity Map” resource can be used to find connections among small molecules sharing a mechanism of action, chemicals and physiological processes, and diseases and drugs. These results indicate the feasibility of the approach and suggest the value of a large-scale community Connectivity Map project.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, post-perturbation transcriptomics data are particularly suited for training computational models because the causal relationship between known perturbations (cause) and the measured post-perturbation gene expression (effect) allows for the modelling of mechanistic processes [11].”
From Benchmarking foundation cell models for post-perturbation RNA-seq prediction (2025) · cites this paper as [11]
In the citing paper
“Both Alakwaa’ and Luo’s pipelines use the CLUE platform, a cloud-based platform developed by the LINCS Center for signature-gene based drug ranking61.”
From ASGARD is a single-cell guided pipeline to aid repurposing of drugs (2023) · cites this paper as [61]
In the citing paper
“For example, in a classic paradigm inflammatory bowel disease (IBD) signatures were derived from surgical specimens and intersected with Connectivity Map70 data representing transcriptional readouts across a number of cell lines in response to treatment with many hundreds of drugs using a novel pattern-matching algorithm71. From this research the anticonvulsant drug topiramate was identified and”
From Exploiting machine learning for end-to-end drug discovery and development (2019) · cites this paper as [71]
In the citing paper
“Useful tools will include maps of evolutionary conservation (108) and chromatin state (140), as well as databases of cell-state signatures, such as genome-wide expression patterns, that may integrate aspects of cell biology under resting and provoked conditions (141).”
From Genetic Mapping in Human Disease (2008) · cites this paper as [141]
In the citing paper
“It has been shown that compounds eliciting similar transcriptional signatures tend to share mechanisms of action.170,207−209”
From Advancing Targeted Protein Degradation via Multiomics Profiling and Artificial Intelligence (2023) · cites this paper as [207]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Self-citationMolecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516
Self-citationMootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Self-citationGene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Nonparametric Statistical Methods
(1999) · Technometrics · doi:10.1080/00401706.1999.10485954 · Cited by 6,090
Exploring the Metabolic and Genetic Control of Gene Expression on a Genomic Scale
DeRisi, J. L., Iyer, V. R., & Brown, P. O. (1997) · Science · doi:10.1126/science.278.5338.680 · Cited by 4,456
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,625
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90193-0 · Cited by 2,858
Functional Discovery via a Compendium of Expression Profiles
Hughes, T. R., Marton, M. J., Jones, A. R., Roberts, C. J., Stoughton, R., Armour, C. D., Bennett, H. A., Coffey, E., Dai, H., He, Y. D., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)00015-5 · Cited by 2,533
Research works printed but not linked: 7
- K. B. Glaser et al., Mol. Cancer Ther.2, 151 (2003).
- A. E. Wakeling, M. Dukes, J. Bowler, Cancer Res.51, 3867 (1991).
- J. Y. Vanderhoek, M. B. Feinstein, Mol. Pharmacol.16, 171 (1979).
- H. Hieronymus et al. Cancer Cell in press.
- Q. Yao et al., Clin. Cancer Res.9, 4483 (2003).
- T. Kubota et al., Cancer Res.58, 3344 (1998).
- G. Wei et al. Cancer Cell in press.
Cited by
Items 901–1,000 of 1,037
Optimal Drug Prediction From Personal Genomics Profiles
Sheng, J., Li, F., & Wong, S. T. C. (2015) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2015.2412522 · Cited by 70
Su, Y., Tang, W., Cheng, Y., Sia, P., Huang, C.-C. S., Lee, Y., Jiang, H.-Y., Wu, M., Lai, I., Lee, J.-W., et al. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.05.012 · Cited by 70
Towards precision medicine for stress disorders: diagnostic biomarkers and targeted drugs
Le-Niculescu, H., Roseberry, K., Levey, D. F., Rogers, J., Kosary, K., Prabha, S., Jones, T., Judd, S., McCormick, M. A., Wessel, A. R., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0370-z · Cited by 62
Mukherjee, P. K., Banerjee, S., & Kar, A. (2021) · Phytochemistry Reviews · doi:10.1007/s11101-020-09730-4 · Cited by 69
Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19
Le, B. L., Andreoletti, G., Oskotsky, T., Vallejo-Gracia, A., Rosales, R., Yu, K., Kosti, I., Leon, K. E., Bunis, D. G., Li, C., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-91625-1 · Cited by 69
Nie, S., Yan, X., Chen, G., Ma, K., Han, C., Guo, Z., Zhang, Z., Ye, K., & Cao, X. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.08.016 · Cited by 69
Bisphosphonates inactivate human EGFRs to exert antitumor actions
Yuen, T., Stachnik, A., Iqbal, J. Z., Sgobba, M., Gupta, Y. K., Lü, P., Colaianni, G., Ji, Y., Zhu, L.-L., Kim, S., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421410111 · Cited by 69
Varadarajan, S., Bampton, E. T. W., Smalley, J. L., Tanaka, K., Caves, R. E., Butterworth, M., Wei, J., Pellecchia, M., Mitcheson, J. S., Gant, T. W., et al. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.108 · Cited by 69
Established and Emerging Trends in Computational Drug Discovery in the Structural Genomics Era
Taboureau, O., Baell, J. B., Fernández‐Recio, J., & Villoutreix, B. O. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.12.007 · Cited by 70
Helal, K. Y., Maciejewski, M., Gregori‐Puigjané, E., Glick, M., & Wassermann, A. M. (2016) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00498 · Cited by 69
Web-based drug repurposing tools: a survey
Sam, E., & Athri, P. (2017) · Briefings in Bioinformatics · doi:10.1093/bib/bbx125 · Cited by 70
Systematic exploration of cell morphological phenotypes associated with a transcriptomic query
Nassiri, I., & McCall, M. N. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky626 · Cited by 61
The anti-psychotic drug pimozide is a novel chemotherapeutic for breast cancer
Dakir, E. H., Pickard, A., Srivastava, K., McCrudden, C. M., Gross, S. R., Lloyd, S., Zhang, S., Margariti, A., Morgan, R., Rudland, P. S., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.26175 · Cited by 70
Bushel, P. R., Paules, R. S., & Auerbach, S. S. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00485 · Cited by 69
Podocyte histone deacetylase activity regulates murine and human glomerular diseases
Inoue, K., Gan, G., Ciarleglio, M. M., Zhang, Y., Tian, X., Pedigo, C. E., Cavanaugh, C. J., Tate, J., Wang, Y., Cross, E., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124030 · Cited by 69
Choose and Use Your Chemical Probe Wisely to Explore Cancer Biology
Blagg, J., & Workman, P. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.07.010 · Cited by 70
Importin α3 regulates chronic pain pathways in peripheral sensory neurons
Marvaldi, L., Panayotis, N., Alber, S., Dagan, S. Y., Okladnikov, N., Koppel, I., Pizio, A. D., Song, D., Tzur, Y., Terenzio, M., et al. (2020) · Science · doi:10.1126/science.aaz5875 · Cited by 69
Douglass, E. F., Allaway, R. J., Szalai, B., Wang, W., Tian, T., Fernández-Torras, A., Realubit, R., Karan, C., Zheng, S., Pessia, A., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100492 · Cited by 68
Regan, K., Xu, J., DiVincenzo, M. J., Duggan, M. C., Shakya, R., Na, R., Carson, W. E., Payne, P., & Li, F. (2019) · npj Systems Biology and Applications · doi:10.1038/s41540-019-0085-4 · Cited by 68
Shen, Y., Liu, J., Zhang, L., Dong, S., Zhang, J., Liu, Y., Zhou, H., & Dong, W. (2019) · BioMed Research International · doi:10.1155/2019/7376034 · Cited by 68
Zheng, S., Liang, J., Tang, Y., Xie, J., Zou, Y., Yang, A., Shao, N., Kuang, X., Ji, F., Liu, X., et al. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1189 · Cited by 68
Jacobs, M. N., Laws, S. C., Willett, K. M., Schmieder, P. K., Odum, J., & Bovee, T. F. H. (2013) · ALTEX · doi:10.14573/altex.2013.3.331 · Cited by 68
Automated Detection of Off-Label Drug Use
Jung, K., LePendu, P., Chen, W. S., Iyer, S. V., Readhead, B., Dudley, J. T., & Shah, N. H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089324 · Cited by 56
Daves, M. H., Hilsenbeck, S. G., Lau, C. C., & Man, T. (2011) · BMC Medical Genomics · doi:10.1186/1755-8794-4-56 · Cited by 68
MeSHDD: Literature-based drug-drug similarity for drug repositioning
Brown, A. S., & Patel, C. J. (2017) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocw142 · Cited by 63
Van Vleet, T. R., Liguori, M. J., Lynch, III, Rao, M., & Warder, S. (2019) · SLAS Discovery · doi:10.1177/2472555218799713 · Cited by 59
Drug Combinations: Mathematical Modeling and Networking Methods
Vakil, V., & Trappe, W. K. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11050208 · Cited by 68
Peng, P., Zhang, B., Huang, J., Xing, C., Liu, W., Sun, C., Guo, W., Yao, S.-Y., Ruan, W., Ning, G., et al. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118039 · Cited by 67
A review of machine learning approaches for drug synergy prediction in cancer
Torkamannia, A., Omidi, Y., & Ferdousi, R. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac075 · Cited by 67
Estrogen hormone is an essential sex factor inhibiting inflammation and immune response in COVID-19
Li, F., Boon, A. C. M., Michelson, A. P., Foraker, R. E., Zhan, M., & Payne, P. (2022) · Scientific Reports · doi:10.1038/s41598-022-13585-4 · Cited by 68
Wang, H., Liu, J., Jiang, Y., Wang, Z., Zhang, Z., Peng, J., Wang, Y., & Li, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.943389 · Cited by 69
Lv, Y., Wu, L., Jian, H., Zhang, C., Lou, Y., Kang, Y., Hou, M., Li, Z., Li, X., Sun, B., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.997765 · Cited by 67
Decoding Connectivity Map-based drug repurposing for oncotherapy
Zhao, Y., Chen, X., Chen, J., & Qi, X. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad142 · Cited by 67
Limonoids from neem ( Azadirachta indica A. Juss.) are potential anticancer drug candidates
Nagini, S., Palrasu, M., & Bishayee, A. (2023) · Medicinal Research Reviews · doi:10.1002/med.21988 · Cited by 67
Huang, Y., Yeh, H., & Soo, V. (2013) · BMC Medical Genomics · doi:10.1186/1755-8794-6-s3-s4 · Cited by 67
Krakstad, C., Trovik, J., Wik, E., Engelsen, I. B., Werner, H. M. J., Birkeland, E., Raeder, M. B., Øyan, A. M., Stefansson, I. M., Kalland, K. H., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.91 · Cited by 61
Xu, R., Li, L., & Wang, Q. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt359 · Cited by 60
Beglyarova, N., Banina, E., Zhou, Y., Mukhamadeeva, R., Andrianov, G., Bobrov, E., Lysenko, E., Skobeleva, N., Gabitova, L., Restifo, D., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0149 · Cited by 61
Network-Based Drug Repositioning: Approaches, Resources, and Research Directions
Alaimo, S., & Pulvirenti, A. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8955-3_6 · Cited by 67
Bickel, D., & Gohlke, H. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.115080 · Cited by 67
Rivera, A. D., & Butt, A. M. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0542-2 · Cited by 64
Williams, G., Gatt, A., Clarke, E., Corcoran, J., Doherty, P., Chambers, D., & Ballard, C. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0555-x · Cited by 69
Zheng, W., Wu, J., Gu, J., Weng, H., Wang, J., Wang, T., Liang, X., & Cao, L. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00147 · Cited by 67
Computational Drug Repositioning: Current Progress and Challenges
Ko, Y. (2020) · Applied Sciences · doi:10.3390/app10155076 · Cited by 67
Podocyte Aging: Why and How Getting Old Matters
Shankland, S. J., Wang, Y., Shaw, A., Vaughan, J., Pippin, J. W., & Wessely, O. (2021) · Journal of the American Society of Nephrology · doi:10.1681/asn.2021050614 · Cited by 67
Chan, J. N. Y., Vuckovic, D., Sleno, L., Olsen, J. B., Pogoutse, O., Havugimana, P. C., Hewel, J. A., Bajaj, N., Wang, Y., Musteata, F. M., et al. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.016642 · Cited by 67
Berg, E. L., Hsu, Y.-C., & Lee, J. A. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.01.013 · Cited by 66
Pathway Analysis Tools and Toxicogenomics Reference Databases for Risk Assessment
Ganter, B., Zidek, N., Hewitt, P., Müller, D., & Vladimirova, A. (2007) · Pharmacogenomics · doi:10.2217/14622416.9.1.35 · Cited by 66
Zhong, Y., Chen, E. Y., Liu, R., Chuang, P. Y., Mallipattu, S. K., Tan, C. M., Clark, N. R., Deng, Y., Klotman, P. E., Ma’ayan, A., et al. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012060590 · Cited by 66
Guedj, F., Pennings, J. L., Massingham, L. J., Wick, H. C., Siegel, A. E., Tantravahi, U., & Bianchi, D. W. (2016) · Scientific Reports · doi:10.1038/srep32353 · Cited by 58
Drug repositioning: current approaches and their implications in the precision medicine era
Talevi, A. (2018) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2018.1424535 · Cited by 67
Drug-pathway association prediction: from experimental results to computational models
Wang, C.-C., Zhao, Y., & Chen, X. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa061 · Cited by 66
Nuisance compounds in cellular assays
Dahlin, J. L., Auld, D. S., Rothenaigner, I., Haney, S., Sexton, J. Z., Nissink, J. W. M., Walsh, J. J., Lee, J. A., Strelow, J. M., Willard, F. S., et al. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.01.021 · Cited by 66
Xue, Y., Chen, C., Tan, R., Zhang, J., Fang, Q., Jin, R., Mi, X., Sun, D., Xue, Y., Wang, Y., et al. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c08994 · Cited by 65
Proteogenomic insights suggest druggable pathways in endometrial carcinoma
Dou, Y., Katsnelson, L., Gritsenko, M., Hu, Y., Reva, B. A., Hong, R., Wang, Y.-T., Kołodziejczak, I., Lu, R. J.-H., Tsai, C., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.07.007 · Cited by 65
DMAP: a connectivity map database to enable identification of novel drug repositioning candidates
Huang, H., Nguyen, T., Ibrahim, S., Shantharam, S., Yue, Z., & Chen, J. Y. (2015) · BMC Bioinformatics · doi:10.1186/1471-2105-16-s13-s4 · Cited by 55
Berg, A., Høivik, E. A., Mjøs, S., Holst, F., Werner, H. M. J., Tangen, I. L., Taylor-Weiner, A. N., Gibson, W. J., Kusonmano, K., Wik, E., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2675 · Cited by 65
Piperlongumine induces inhibition of the ubiquitin–proteasome system in cancer cells
Jarvius, M., Fryknäs, M., D’Arcy, P., Sun, C., Rickardson, L., Gullbo, J., Haglund, C., Nygren, P., Linder, S. T., & Larsson, R. L. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.01.017 · Cited by 65
Allain, C., Angenard, G., Clément, B., & Coulouarn, C. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-1559 · Cited by 65
In silico models in drug development: where we are
Piñero, J., Furlong, L. I., & Sanz, F. (2018) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2018.08.007 · Cited by 68
β-sitosterol reduces anxiety and synergizes with established anxiolytic drugs in mice
Panayotis, N., Freund, P. A., Marvaldi, L., Shalit, T., Brandis, A. S., Mehlman, T., Tsoory, M., & Fainzilber, M. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100281 · Cited by 65
Williams, G. H. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-12 · Cited by 65
Poussin, C., Mathis, C., Alexopoulos, L. G., Messinis, D. E., Dulize, R., Belcastro, V., Melas, I. N., Sakellaropoulos, T., Rhrissorrakrai, K., Bilal, E., et al. (2014) · Scientific Data · doi:10.1038/sdata.2014.9 · Cited by 65
Regan, K., Li, D., Reyes, R., Yu, L., Wani, N. A., Hu, P., Jacob, S. T., Ghoshal, K., Payne, P., & Motiwala, T. (2020) · Cancers · doi:10.3390/cancers12102730 · Cited by 68
Jiang, R., Su, G., Chen, X., Chen, S., Li, Q., Xie, B., & Zhao, Y. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.08.039 · Cited by 64
Vitexin inhibits APEX1 to counteract the flow-induced endothelial inflammation
Zhao, C., Yang, F., Cui, Q., Wang, D., Zhou, Y., Li, Y.-S. J., Zhang, Y., Tang, R.-Z., Yao, W., Wang, X., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2115158118 · Cited by 64
Su, C., Hou, Y., Xu, J., Xu, Z., Zhou, M., Ke, A., Li, H., Xu, J., Brendel, M., Maasch, J. R. M. A., et al. (2024) · npj Digital Medicine · doi:10.1038/s41746-024-01175-9 · Cited by 65
Pojo, M., Gonçalves, C. S., Xavier‐Magalhães, A., Oliveira, A. I., Gonçalves, T., Correia, S., Rodrigues, A. J., Costa, S., Pinto, L., Pinto, A. A., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3150 · Cited by 64
Lin, W., Cerny, D., Chua, E., Duan, K., Yi, J. T. J., Shadan, N. B., Lum, J., Maho‐Vaillant, M., Zolezzi, F., Wong, S. C., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303214 · Cited by 64
Saito, S., Furuno, A., Sakurai, J., Park, H. R., Shin‐ya, K., & Tomida, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045845 · Cited by 65
Stem Cell Origin of Death-from-Cancer Phenotypes of Human Prostate and Breast Cancers
Glinsky, G. V. (2007) · Stem Cell Reviews and Reports · doi:10.1007/s12015-007-0011-9 · Cited by 64
Yu, K. H., Ricigliano, M., Hidalgo, M. M., Abou‐Alfa, G. K., Lowery, M. A., Saltz, L. B., Crotty, J. F., Gary, K., Cooper, B., Lapidus, R. S., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0531 · Cited by 64
Drug Discovery in a Multidimensional World: Systems, Patterns, and Networks
Dudley, J. T., Schadt, E. E., Sirota, M., Butte, A. J., & Ashley, E. A. (2010) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-010-9214-6 · Cited by 65
Accelerating fluorescent sensor discovery: unbiased screening of a diversity-oriented BODIPY library
Lee, J., Kim, H. K., Feng, S., Vendrell, M., & Chang, Y. (2010) · Chemical Communications · doi:10.1039/c0cc04495d · Cited by 64
Chen, H.-R., Sherr, D. H., Hu, Z., & DeLisi, C. (2016) · BMC Medical Genomics · doi:10.1186/s12920-016-0212-7 · Cited by 64
Synergistic antileukemic therapies in NOTCH1 -induced T-ALL
Sánchez-Martín, M., Ambesi‐Impiombato, A., Qin, Y., Herranz, D., Bansal, M., Girardi, T., Paietta, E. M., Tallman, M. S., Rowe, J. M., Keersmaecker, K. D., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1611831114 · Cited by 64
DrugSig: A resource for computational drug repositioning utilizing gene expression signatures
Wu, H., Huang, J., Zhong, Y., & Huang, Q. (2017) · PLOS ONE · doi:10.1371/journal.pone.0177743 · Cited by 60
Targeting Bromodomain and Extraterminal Proteins in Breast Cancer
Sahni, J. M., & Keri, R. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.11.015 · Cited by 48
Enache, O. M., Lahr, D. L., Natoli, T., Litichevskiy, L., Wadden, D., Flynn, C., Gould, J., Asiedu, J. K., Narayan, R., & Subramanian, A. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty784 · Cited by 64
Self-citationRBMS1 Suppresses Colon Cancer Metastasis through Targeted Stabilization of Its mRNA Regulon
Yu, J. X., Navickas, A., Asgharian, H., Culbertson, B., Fish, L., Garcia, K., Olegario, J. P., Dermit, M., Dodel, M., Hänisch, B., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-1375 · Cited by 64
Drug Repurposing for Triple-Negative Breast Cancer
Ávalos-Moreno, M., López-Tejada, A., Blaya-Cánovas, J. L., Cara, F. E., González-González, A., Lorente, J. A., Sánchez‐Rovira, P., & Granados-Principal, S. M. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10040200 · Cited by 66
A high-throughput screen identifies that CDK7 activates glucose consumption in lung cancer cells
Ghezzi, C., Wong, A., Chen, B. Y., Ribalet, B., Damoiseaux, R. D., & Clark, P. M. (2019) · Nature Communications · doi:10.1038/s41467-019-13334-8 · Cited by 63
Peng, Y., Yuan, M., Xin, J., Liu, X., & Wang, J. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa563 · Cited by 64
Drug Repurposing: Claiming the Full Benefit from Drug Development
Kort, E. J., & Jovinge, S. V. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01484-5 · Cited by 63
Guo, Q., Linglin, Z., Yan, N., Li, Y., Guo, C., Dang, S., Shen, X., Jian-fang, H., & Luo, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1148056 · Cited by 64
New horizons at the interface of artificial intelligence and translational cancer research
Yates, J., & Allen, E. M. V. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.03.018 · Cited by 63
Hsp90 Modulation for the Treatment of Alzheimer’s Disease
Zhao, H., Michaelis, M. L., & Blagg, B. S. J. (2012) · Advances in pharmacology · doi:10.1016/b978-0-12-394816-8.00001-5 · Cited by 63
The role of translational bioinformatics in drug discovery
Buchan, N. S., Rajpal, D. K., Webster, Y., Alatorre, C., Gudivada, R. C., Zheng, C., Sanséau, P., & Koehler, J. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.03.002 · Cited by 63
On the Path to Seeking Novel Radiosensitizers
Katz, D., Ito, E., & Liu, F. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.12.002 · Cited by 63
Engerud, H., Tangen, I. L., Berg, A., Kusonmano, K., Halle, M. K., Oyan, A. M., Kalland, K., Stefansson, I. M., Trovik, J., Salvesen, H. B., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.262 · Cited by 63
Choi, Y. E., Battelli, C., Watson, J., Liu, J. F., Curtis, J. D., Morse, A., Matulonis, U. A., Chowdhury, D., & Konstantinopoulos, P. A. (2014) · Oncotarget · doi:10.18632/oncotarget.1929 · Cited by 63
Microfluidic-Based Multi-Organ Platforms for Drug Discovery
Rezaei Kolahchi, A., Khadem Mohtaram, N., Pezeshgi Modarres, H., Mohammadi, M., Geraili, A., Jafari, P., Akbari, M., & Sanati-Nezhad, A. (2016) · Micromachines · doi:10.3390/mi7090162 · Cited by 53
Paradigm shift in natural product research: traditional medicine inspired approaches
Mukherjee, P. K., Bahadur, S., Harwansh, R. K., Biswas, S., & Banerjee, S. (2017) · Phytochemistry Reviews · doi:10.1007/s11101-016-9489-6 · Cited by 63
ReSimNet: drug response similarity prediction using Siamese neural networks
Jeon, M., Park, D., Lee, J., Jeon, H., Ko, M., Kim, S., Choi, Y., Tan, A. C., & Kang, J. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz411 · Cited by 63
Chemoproteomic-enabled phenotypic screening
Conway, L. P., Li, W., & Parker, C. G. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.01.012 · Cited by 63
High-content phenotypic and pathway profiling to advance drug discovery in diseases of unmet need
Hughes, R. E., Elliott, R. J. R., Dawson, J. C., & Carragher, N. O. (2021) · Cell Chemical Biology · doi:10.1016/j.chembiol.2021.02.015 · Cited by 62
Ribeiro, R., Macedo, J. C., Costa, M., Ustiyan, V., Shindyapina, A. V., Tyshkovskiy, A., Gomes, R. N., Castro, J. P., Kalin, T. V., Vasques-Nóvoa, F., et al. (2022) · Nature Aging · doi:10.1038/s43587-022-00209-9 · Cited by 60
Apigenin Enhances Skeletal Muscle Hypertrophy and Myoblast Differentiation by Regulating Prmt7
Jang, Y. J., Son, H. J., Choi, Y. M., Ahn, J., Jung, C. H., & Ha, T. Y. (2017) · Oncotarget · doi:10.18632/oncotarget.20962 · Cited by 59
ASGARD is a single-cell guided pipeline to aid repurposing of drugs
He, B., Xiao, Y., Liang, H., Huang, Q., Du, Y., Li, Y., Garmire, D., Sun, D., & Garmire, L. X. (2023) · Nature Communications · doi:10.1038/s41467-023-36637-3 · Cited by 57
Astrocyte-specific transcriptome responses to chronic ethanol consumption
Erickson, E. K., Farris, S. P., Blednov, Y. A., Mayfield, R. D., & Harris, R. A. (2018) · The Pharmacogenomics Journal · doi:10.1038/s41397-017-0012-2 · Cited by 56
Metadata
- Authors
- Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., Reich, M., Hieronymus, H., Wei, G., Armstrong, S. A., Haggarty, S. J., Clemons, P. A., Wei, R., Carr, S. A., Lander, E. S., & Golub, T. R.
- Affiliations
- Broad Institute (US)
- Corresponding author
- Lamb, Justin
- Crawford, Emily D.
- Golub, Todd R.
- ORCID
- Venue
- Science
- Published
- 2006-09-29
- Volume
- 313
- Issue
- 5795
- Pages
- 1929-1935
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2121604817
- Cited by
- 5,257
- References
- 41
- Citations by year
- 2026: 226 · 2025: 285 · 2024: 332 · 2023: 370 · 2022: 416 · 2021: 406 · 2020: 383 · 2019: 385 · 2018: 280 · 2017: 288 · 2016: 296 · 2015: 259 · 2014: 217 · 2013: 241 · 2012: 219
- FWCI
- 118.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Keywords
- Connectivity Map, gene expression signatures, small molecules, drug action, gene perturbation, mechanism of action, cultured human cells, functional genomics
- MeSH terms
- Alzheimer Disease, Cell Line, Dexamethasone, Drug Evaluation, Preclinical, Enzyme Inhibitors, Estrogens, Humans, Obesity, Phenothiazines, Software, Gene Expression, Databases, Factual, HSP90 Heat-Shock Proteins, Drug Resistance, Neoplasm, Sirolimus, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Limonins, Cell Line, Tumor, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Histone Deacetylase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.